This grant has ended and is part of our past portfolio of work.
VIGH and The Institute for Medicine and Public Health are partnering with the Shanghai Municipal Center for Disease Control (Shanghai CDC) and Prevention, Fudan University, and the Shanghai Cancer Institute (SCI) to establish the Vanderbilt-Shanghai Chronic Disease Research Training Program (VU-Shanghai CDRTP) to train the next generation of chronic disease researchers and build research capacity and local training facilities in China. This program will have a significant impact on chronic disease research and prevention in China, and possibly extend to other developing countries.
The CDRTP will: (1) train a cadre of experts to conduct multi-disciplinary research in chronic disease and build training capacity in China; (2) train a new generation of scientists and future leaders in chronic disease research in China; (3) build research capacity in China and to establish long-term collaborative relationships with Vanderbilt chronic disease researchers; (4) ensure and document the long-term success of the training program in China as facilitated and upgraded through this award; and (5) build national and international leadership in chronic disease research and prevention through existing and newly established networks. The training program includes short-term scholar training (3 months at Vanderbilt), graduate training (1-2 years of didactic course work at Fudan University, a 3-month research practicum at the Shanghai CDC or SCI, and 1 year of thesis research at Vanderbilt), workshops, and an international conference.
The training will focus on advanced epidemiological and biostatistical methodology, design and execution of multidisciplinary research projects, and building expertise on cancer, cardiovascular disease and diabetes research, as well as grant writing skills. The Vanderbilt-Shanghai CDRTP, building upon the strength of existing research and training programs and long-standing collaborations among the participating institutes, will have a significant and long-term impact on chronic disease research and prevention in China.
For more information contact Han-Zhu Qian, M.D., Ph.D., Program Director.